Business Context and Reporting Period
This Form 6-K filing was submitted by GlaxoSmithKline plc, GlaxoSmithKline Capital plc, and GlaxoSmithKline Capital Inc. on May 9, 2012. The registrants are headquartered in Brentford, Middlesex, and Wilmington, Delaware. The filing serves to incorporate legal opinions by reference into a Registration Statement on Form F-3 (File No. 333-172621).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing regarding legal opinions and does not contain financial performance data.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. No financial or operational comparisons are included in this specific report.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document focuses solely on the incorporation of legal opinions from Cleary Gottlieb Steen & Hamilton LLP (Exhibits 5.1 and 5.2) into the Form F-3 registration statement.
Investor Verification Points
- Verify the status of the Registration Statement on Form F-3 (File No. 333-172621) referenced in this filing.
- Review the specific legal opinions provided in Exhibits 5.1 and 5.2 regarding U.S. and English counsel.
- Consult the company's most recent Form 20-F or quarterly reports for actual financial performance data, as this Form 6-K contains none.